quinacrine has been researched along with Lymphoma in 8 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Because the antigenic changes occurring after in vivo treatment of murine lymphoma cells with 5-(3,3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide (DTIC) were suggested to result from DTIC-induced somatic mutation(s), quinacrine dihydrochloride, an antimutagenic compound, was tested for possible antagonistic activity related to this phenomenon." | 3.66 | Drug-mediated antigenic changes in murine leukemia cells: antagonistic effects of quinacrine, an antimutagenic compound. ( Bonmassar, E; Fioretti, MC; Giampietri, A; Goldin, A, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giampietri, A | 1 |
| Fioretti, MC | 2 |
| Goldin, A | 1 |
| Bonmassar, E | 1 |
| Whang-Peng, J | 1 |
| Garson, OM | 1 |
| Kreuser, ED | 1 |
| Puccetti, P | 1 |
| Fuschiotti, P | 1 |
| Dominici, P | 1 |
| Borri-Voltattorni, C | 1 |
| Romani, L | 1 |
| Russell, DH | 1 |
| Buckley, AR | 1 |
| Montgomery, DW | 1 |
| Larson, NA | 1 |
| Gout, PW | 1 |
| Beer, CT | 1 |
| Putnam, CW | 1 |
| Zukoski, CF | 1 |
| Kibler, R | 1 |
| Ofenstein, JP | 1 |
| Rillema, JA | 1 |
| Hiller, E | 1 |
| Rosenow, EC | 1 |
| Olsen, AM | 1 |
2 reviews available for quinacrine and Lymphoma
| Article | Year |
|---|---|
Chromosome-banding techniques and their implication in hematology.
Topics: Acute Disease; Azure Stains; Cell Transformation, Neoplastic; Chromosome Aberrations; Chromosome Ban | 1979 |
[Malignant pleural effusions. Pathophysiology, diagnosis and therapy].
Topics: Absorption; Amylases; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Capillary Permea | 1985 |
6 other studies available for quinacrine and Lymphoma
| Article | Year |
|---|---|
Drug-mediated antigenic changes in murine leukemia cells: antagonistic effects of quinacrine, an antimutagenic compound.
Topics: Animals; Antigens, Neoplasm; Dacarbazine; Immunity; Leukemia, Experimental; Lymphoma; Male; Mice; Mi | 1980 |
Banding in leukemia: techniques and implications.
Topics: Aneuploidy; Azure Stains; Bone Marrow; Bone Marrow Cells; Cell Division; Chromosome Aberrations; Chr | 1977 |
DNA methylating activity in murine lymphoma cells xenogenized by triazene derivatives.
Topics: Animals; Azacitidine; Carmustine; Cell Line; Cytarabine; Dacarbazine; DNA, Neoplasm; Lymphoma; Male; | 1987 |
Prolactin-dependent mitogenesis in Nb 2 node lymphoma cells: effects of immunosuppressive cyclopeptides.
Topics: Animals; Calcimycin; Cell Division; Cyclosporins; Depsipeptides; DNA; Enzyme Induction; Estradiol; G | 1987 |
Possible involvement of the phospholipases in the mitogenic actions of prolactin (PRL) on Nb2 node lymphoma cells.
Topics: Acetophenones; Animals; Arachidonic Acid; Arachidonic Acids; Cell Division; Cell Line; Lymphoma; Pho | 1987 |
Pulmonary manifestations of the yellow nail syndrome.
Topics: Adolescent; Adult; Aged; Bronchiectasis; Cough; Disease Susceptibility; Female; Humans; Lymphedema; | 1972 |